Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation
Ameri, HosseinVolume:
30
Language:
english
Journal:
Journal of Current Ophthalmology
DOI:
10.1016/j.joco.2018.01.006
Date:
March, 2018
File:
PDF, 179 KB
english, 2018